Buenos Aires - - Wednesday 12 De May

Home Argentine Knowledge Every day closer to the drug against HSUH

Every day closer to the drug against HSUH

Specialists from the Italian Hospital and Conicet advance in the creation of a serum for the treatment of Hemolytic Uremic Syndrome.


A group of medical  specialists from the Italian Hospital and  CONICET scientists announced the development of a new serum for the treatment of the dreaded hemolytic uremic syndrome (HUS) that does not have a specific treatment available and is the first cause of acute renal failure in children.

They reported that he successfully developed the initial phase of a human clinical trial for this treatment 

 The new serum could become the first drug in the world to prevent the progression of this disease.  U na food poisoning transmitted by consumption of food contaminated with the bacteria Escherichia coli. Producer of Shiga toxin (STEC). It's known as the “raw hamburger disease.” But the bacterium is also found in fruits and vegetables or unpasteurized milk.

 “ At this stage we demonstrated the safety of the product, allowing us to start trials to test its effectiveness in children.  Something we'll start in the next few months, at least ten hospitals. Children who arrive with diarrhea with blood and whose parents agree to enter the study (via informed consent) will be given this medication to see if it prevents development.” He said Fernando Goldbaum, scientific director of the Immunova laboratory and researcher at Conicet.

Faced with the urgent need for  specific therapies , researchers from the Immunova laboratory -a biotechnological start up that emerged nine years ago from the  Leloir Institute - and the Institute of Experimental Medicine -dependent on the Academy of Medicine and CONICET - developed an innovative biological drug.

In the first phase of experimentation 14 people participated from the Registry of Healthy Volunteers of the Italian Hospital. They received the serum intravenously.  The test showed “an excellent safety profile and pharmacokinetics (distribution of the drug in the body). Very suitable for further application “, reported the Italian Hospital.

By the end of the year it is planned to start the clinical trial Phase 2/3. It will be developed with a team of pediatricians and pediatric nephrologists from all over the country. Within two years,  the new serum “could become the first drug in the world to prevent the progression of this disease .” The main cause of acute renal failure and responsible for 20 percent of kidney transplants in children and adolescents globally.


Publication Date: 30/04/2019

Rate this item



I wrote! Reader Notes

Go to section


There are not comments

Leave feedback


Argentines around the world
 Comodoro Rivadavia A chubutense that does not go unnoticed in Brazil

Pablo Rodríguez is born and raised in Comodoro Rivadavia and currently presides over the Brazilian S...

Mirtha Legrand Another season without Mirtha Legrand?

The second season of the dinners and lunches now driving his granddaughter Juana Viale keeps a good...

Perón Domingo Antonio Raso, the man who took care of Perón

Domingo Antonio Raso's life was anonymous as his responsibility: he had to guard the leader of justi...

Health and Esthetics
Vida de Yoguini Moderna - práctica para relajar la espalda Yoga to relax your back

Today Patrizia brings us a quiet practice, suitable for all levels, to relax the upper back area, wh...



I want to be up to date

Subscribe to our newsletter and I received the latest news